tiprankstipranks
Athens Medical Center SA (GB:0ONM)
LSE:0ONM
UK Market
0ONM
Athens Medical Center
RESEARCH TOOLSreports

Athens Medical Center (0ONM) Ratios

0 Followers

Athens Medical Center Ratios

GB:0ONM's free cash flow for Q2 2025 was €0.20. For the 2025 fiscal year, GB:0ONM's free cash flow was decreased by € and operating cash flow was €0.06. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
 0.81 0.83 0.98 1.10 1.21
Quick Ratio
 0.79 0.80 0.95 1.05 1.16
Cash Ratio
 0.10 0.08 0.11 0.11 0.77
Solvency Ratio
 0.02 0.05 0.06 0.07 0.02
Operating Cash Flow Ratio
 0.11 0.20 0.13 <0.01 0.12
Short-Term Operating Cash Flow Coverage
 0.36 0.82 0.52 <0.01 0.94
Net Current Asset Value
€ -196.75M€ -195.18M€ -171.58M€ -155.01M€ -1.46B
Leverage Ratios
Debt-to-Assets Ratio
 0.31 0.30 0.33 0.34 0.08
Debt-to-Equity Ratio
 1.51 1.36 1.46 1.40 1.48
Debt-to-Capital Ratio
 0.60 0.58 0.59 0.58 0.60
Long-Term Debt-to-Capital Ratio
 0.36 0.39 0.45 0.52 0.53
Financial Leverage Ratio
 4.79 4.57 4.39 4.05 17.87
Debt Service Coverage Ratio
 0.21 0.44 0.54 1.11 1.38
Interest Coverage Ratio
 0.60 1.43 2.44 2.37 3.20
Debt to Market Cap
 0.99 0.97 0.87 1.04 0.91
Interest Debt Per Share
 2.02 1.82 1.94 1.75 1.81
Net Debt to EBITDA
 6.54 4.06 3.61 3.95 1.31
Profitability Margins
Gross Profit Margin
19.45%22.52%25.76%24.34%25.57%
EBIT Margin
2.50%5.63%8.85%7.88%10.06%
EBITDA Margin
7.83%11.86%14.63%13.82%15.76%
Operating Profit Margin
2.20%5.65%8.94%7.89%9.46%
Pretax Profit Margin
-1.15%1.67%5.30%4.59%6.79%
Net Profit Margin
-1.74%0.66%3.13%2.93%6.66%
Continuous Operations Profit Margin
-1.83%0.70%3.16%2.96%5.33%
Net Income Per EBT
151.76%39.59%58.99%63.90%98.12%
EBT Per EBIT
-52.10%29.46%59.31%58.21%71.77%
Return on Assets (ROA)
-0.90%0.36%1.69%1.64%0.83%
Return on Equity (ROE)
-4.33%1.64%7.44%6.63%14.75%
Return on Capital Employed (ROCE)
2.33%5.75%8.34%6.75%1.27%
Return on Invested Capital (ROIC)
1.73%1.95%4.12%4.02%1.55%
Return on Tangible Assets
-0.91%0.36%1.70%1.64%0.83%
Earnings Yield
-3.12%1.36%4.98%5.56%10.27%
Efficiency Ratios
Receivables Turnover
 1.52 1.69 1.64 1.83 2.40
Payables Turnover
 1.89 2.01 2.12 2.20 2.66
Inventory Turnover
 28.50 29.01 27.63 25.22 24.03
Fixed Asset Turnover
 0.93 0.92 0.95 0.92 0.30
Asset Turnover
 0.52 0.54 0.54 0.56 0.12
Working Capital Turnover Ratio
 -6.13 -12.79 46.92 11.00 -10.83
Cash Conversion Cycle
 60.37 46.16 63.80 48.62 29.81
Days of Sales Outstanding
 240.92 215.43 223.09 199.77 151.92
Days of Inventory Outstanding
 12.81 12.58 13.21 14.48 15.19
Days of Payables Outstanding
 193.36 181.85 172.50 165.63 137.30
Operating Cycle
 253.72 228.01 236.30 214.25 167.11
Cash Flow Ratios
Operating Cash Flow Per Share
 0.35 0.54 0.30 <0.01 0.18
Free Cash Flow Per Share
 0.03 0.23 0.04 -0.18 0.05
CapEx Per Share
 0.32 0.31 0.26 0.18 0.13
Free Cash Flow to Operating Cash Flow
 0.10 0.43 0.15 -127.02 0.28
Dividend Paid and CapEx Coverage Ratio
 1.04 1.64 1.17 <0.01 1.39
Capital Expenditure Coverage Ratio
 1.11 1.74 1.17 <0.01 1.40
Operating Cash Flow Coverage Ratio
 0.18 0.32 0.17 <0.01 0.10
Operating Cash Flow to Sales Ratio
 0.11 0.17 0.10 <0.01 0.07
Free Cash Flow Yield
1.94%15.13%2.35%-12.79%3.05%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -31.25 73.62 20.07 17.99 9.74
Price-to-Sales (P/S) Ratio
 0.54 0.49 0.63 0.53 0.65
Price-to-Book (P/B) Ratio
 1.35 1.21 1.49 1.19 1.44
Price-to-Free Cash Flow (P/FCF) Ratio
 50.11 6.61 42.57 -7.82 32.83
Price-to-Operating Cash Flow Ratio
 4.85 2.82 6.20 993.27 9.31
Price-to-Earnings Growth (PEG) Ratio
 0.09 -0.94 1.11 -0.38 0.04
Price-to-Fair Value
 1.35 1.21 1.49 1.19 1.44
Enterprise Value Multiple
 13.48 8.15 7.90 7.77 5.42
Enterprise Value
 291.20M 260.77M 298.74M 250.54M 193.25M
EV to EBITDA
 13.66 8.15 7.90 7.77 5.42
EV to Sales
 1.07 0.97 1.16 1.07 0.86
EV to Free Cash Flow
 98.68 13.16 78.41 -15.91 43.28
EV to Operating Cash Flow
 9.56 5.61 11.42 2.02K 12.27
Tangible Book Value Per Share
 1.19 1.18 1.22 1.18 2.17
Shareholders’ Equity Per Share
 1.27 1.25 1.25 1.19 1.18
Tax and Other Ratios
Effective Tax Rate
 -0.60 0.58 0.40 0.35 0.22
Revenue Per Share
 3.14 3.11 2.98 2.69 2.61
Net Income Per Share
 -0.05 0.02 0.09 0.08 0.17
Tax Burden
 1.52 0.40 0.59 0.64 0.98
Interest Burden
 -0.46 0.30 0.60 0.58 0.67
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.18 0.03 0.02 0.02 0.02
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 16.80 10.33 3.24 0.01 1.03
Currency in EUR